Form 4: COO Daniel Sullivan Departs Edgewell, Forfeits Unvested Equity
Insider Transaction Report
Edgewell Personal Care's Chief Operating Officer, Daniel Sullivan, departed the company on October 1, 2025, resulting in the forfeiture of unvested equity awards and a 90-day window to exercise vested options.
Summary
- Daniel Sullivan, Chief Operating Officer of Edgewell Personal Care Co (EPC), departed the company effective October 1, 2025.
- Upon his departure, Mr. Sullivan forfeited various unvested equity awards, including stock options, restricted stock equivalents (RSEs), and performance restricted stock equivalents (PRSEs).
- Forfeited unvested awards include 6,132 Non-Qualified Stock Options (11/11/2022 grant), 13,848 Non-Qualified Stock Options (11/10/2023 grant), 3,522 RSEs (11/11/2022 grant), 8,182 RSEs (11/10/2023 grant), 17,700 RSEs (11/8/2024 grant), 35,221 PRSEs (11/11/2022 grant), 40,912 PRSEs (11/10/2023 grant), and 53,098 PRSEs (11/8/2024 grant), totaling 178,615 shares.
- Mr. Sullivan retains direct beneficial ownership of 90,418 shares of Common Stock.
- He has a 90-day period from his departure date (October 1, 2025) to exercise his vested stock options, which total 89,649 shares.
Sentiment
Score: 5
Explanation: The filing is a standard Form 4 reporting changes in beneficial ownership due to an executive's departure, which is a neutral event in terms of company performance. It details both forfeited unvested equity and retained vested equity.
Positives
- Edgewell Personal Care avoids future dilution and compensation expense associated with the forfeiture of 178,615 unvested equity awards.
- Daniel Sullivan retains 90,418 shares of common stock.
- Daniel Sullivan has a 90-day window to exercise 89,649 vested stock options.
Negatives
- Daniel Sullivan forfeited a significant number of unvested equity awards upon his departure.
- The departure of a Chief Operating Officer could indicate a loss of institutional knowledge or a need for leadership transition within the company.
Risks
- The departure of a Chief Operating Officer could lead to a temporary disruption in operational leadership and strategic execution.
- Potential for a leadership vacuum or transition challenges until a suitable replacement is found for the Chief Operating Officer role.
Future Outlook
Daniel Sullivan has a 90-day window from October 1, 2025, to exercise his vested stock options. The company will likely need to address the Chief Operating Officer role in the near future.
Management Comments
- Unvested award forfeited upon Mr. Sullivan's departure from the Company on October 1, 2025.
- These options were vested prior to Mr. Sullivan's departure from the Company. He has 90 days from his departure date to exercise them.
- There were no unvested options for this award to forfeit at the time of Mr. Sullivan's departure from the Company. This is the number of vested and exercisable options that he has 90 days to exercise from the date of his departure.
Industry Context
This filing is specific to an individual executive's equity transactions and departure, and does not provide broader industry context or trends.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Operating Officer | Daniel Sullivan | N/A (position vacated) | October 1, 2025 | Departure from the company |
Stakeholder Impact
- Shareholders: Potential impact from executive transition; forfeiture of unvested equity reduces potential future dilution.
- Employees: May experience leadership changes in the operations department.
- Daniel Sullivan: Forfeits unvested equity but retains vested options and common stock, with a limited window to exercise options.
Next Steps
- Daniel Sullivan will need to decide on exercising his vested stock options within 90 days of October 1, 2025.
- Edgewell Personal Care is expected to announce a replacement or succession plan for the Chief Operating Officer role.
Key Dates
| Date | Description |
|---|---|
| 11/14/2019 | Grant date for Non-Qualified Stock Options. |
| 11/13/2020 | Grant date for Non-Qualified Stock Options and Non-Qualified Premium Stock Options. |
| 11/12/2021 | Grant date for Non-Qualified Stock Options. |
| 11/11/2022 | Grant date for Non-Qualified Stock Options, Restricted Stock Equivalent, and Performance Restricted Stock Equivalent. |
| 11/10/2023 | Grant date for Non-Qualified Stock Options, Restricted Stock Equivalent, and Performance Restricted Stock Equivalent. |
| 11/8/2024 | Grant date for Restricted Stock Equivalent and Performance Restricted Stock Equivalent. |
| 10/01/2025 | Daniel Sullivan's departure date from the company and the transaction date for all reported changes in beneficial ownership. |
| 10/02/2025 | Signature date of the reporting person's attorney-in-fact. |
| 90 days from 10/01/2025 | Deadline for Daniel Sullivan to exercise his vested stock options. |
Recommendation
holdThe filing reports the departure of a key executive and the associated changes in his equity ownership. While executive departures can introduce uncertainty, this Form 4 primarily details the mechanics of equity forfeiture and retention, rather than providing new financial performance data or strategic shifts that would warrant an immediate change in investment thesis. Investors should monitor the company's announcement regarding a replacement and any subsequent operational impacts.
Keywords
EPC, Edgewell Personal Care, Form 4, Insider Transaction, Executive Departure, Stock Options, Restricted Stock, Beneficial Ownership, Daniel Sullivan, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.